A non-internalizing anti-CD40 antibody, CHIR-12.12, blocks CD40L-induced cytokine production and mediates greater ADCC than rituximab in primary CLL cells 47th Annual Meeting of the American-Society-of-Hematology Tong, X., Aukerman, S. L., Lin, K., Aziz, N., Goldbeck, C., Georgakis, G. V., Younes, G., Weng, W. K., O'Brien, S., Wierda, W., Jallal, B., Luqman, M. AMER SOC HEMATOLOGY. 2005: 831A–832A

View details for Web of Science ID 000233426005284